210 related articles for article (PubMed ID: 21508125)
1. Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications.
Calvo KR; Vinh DC; Maric I; Wang W; Noel P; Stetler-Stevenson M; Arthur DC; Raffeld M; Dutra A; Pak E; Myung K; Hsu AP; Hickstein DD; Pittaluga S; Holland SM
Haematologica; 2011 Aug; 96(8):1221-5. PubMed ID: 21508125
[TBL] [Abstract][Full Text] [Related]
2. MonoMAC versus idiopathic CD4+ lymphocytopenia. Comment to Haematologica. 2011;96(8):1221-5.
Chu VH; Curry JL; Elghetany MT; Curry CV
Haematologica; 2012 Apr; 97(4):e9-11; author reply e12. PubMed ID: 22492293
[No Abstract] [Full Text] [Related]
3. Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cells.
Bacher U; Haferlach C; Alpermann T; Kern W; Schnittger S; Haferlach T
Haematologica; 2011 Sep; 96(9):1284-92. PubMed ID: 21606170
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cell, monocyte, B and NK lymphoid deficiency defines the lost lineages of a new GATA-2 dependent myelodysplastic syndrome.
Bigley V; Collin M
Haematologica; 2011 Aug; 96(8):1081-3. PubMed ID: 21810969
[No Abstract] [Full Text] [Related]
5. GATA-2 anomaly and clinical phenotype of a sporadic case of lymphedema, dendritic cell, monocyte, B- and NK-cell (DCML) deficiency, and myelodysplasia.
Ishida H; Imai K; Honma K; Tamura S; Imamura T; Ito M; Nonoyama S
Eur J Pediatr; 2012 Aug; 171(8):1273-6. PubMed ID: 22430350
[TBL] [Abstract][Full Text] [Related]
6. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
7. The evolution of cellular deficiency in GATA2 mutation.
Dickinson RE; Milne P; Jardine L; Zandi S; Swierczek SI; McGovern N; Cookson S; Ferozepurwalla Z; Langridge A; Pagan S; Gennery A; Heiskanen-Kosma T; Hämäläinen S; Seppänen M; Helbert M; Tholouli E; Gambineri E; Reykdal S; Gottfreðsson M; Thaventhiran JE; Morris E; Hirschfield G; Richter AG; Jolles S; Bacon CM; Hambleton S; Haniffa M; Bryceson Y; Allen C; Prchal JT; Dick JE; Bigley V; Collin M
Blood; 2014 Feb; 123(6):863-74. PubMed ID: 24345756
[TBL] [Abstract][Full Text] [Related]
8. Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome.
Nováková M; Žaliová M; Suková M; Wlodarski M; Janda A; Froňková E; Campr V; Lejhancová K; Zapletal O; Pospíšilová D; Černá Z; Kuhn T; Švec P; Pelková V; Zemanová Z; Kerndrup G; van den Heuvel-Eibrink M; van der Velden V; Niemeyer C; Kalina T; Trka J; Starý J; Hrušák O; Mejstříková E
Haematologica; 2016 Jun; 101(6):707-16. PubMed ID: 27013649
[TBL] [Abstract][Full Text] [Related]
9. Differential diagnosis of myelofibrosis based on WHO 2008 criteria: acute panmyelosis with myelofibrosis, acute megakaryoblastic leukemia with myelofibrosis, primary myelofibrosis and myelodysplastic syndrome with myelofibrosis.
Bae E; Park CJ; Cho YU; Seo EJ; Chi HS; Jang S; Lee KH; Lee JH; Lee JH; Suh JJ; Im HJ
Int J Lab Hematol; 2013 Dec; 35(6):629-36. PubMed ID: 23693053
[TBL] [Abstract][Full Text] [Related]
10. Assessment of myeloid and monocytic dysplasia by flow cytometry in de novo AML helps define an AML with myelodysplasia-related changes category.
Weinberg OK; Hasserjian RP; Li B; Pozdnyakova O
J Clin Pathol; 2017 Feb; 70(2):109-115. PubMed ID: 27387988
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood.
Aalbers AM; van den Heuvel-Eibrink MM; Baumann I; Dworzak M; Hasle H; Locatelli F; De Moerloose B; Schmugge M; Mejstrikova E; Nováková M; Zecca M; Zwaan CM; Te Marvelde JG; Langerak AW; van Dongen JJ; Pieters R; Niemeyer CM; van der Velden VH
Haematologica; 2015 Mar; 100(3):315-23. PubMed ID: 25425683
[TBL] [Abstract][Full Text] [Related]
12. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia.
Galera P; Dulau-Florea A; Calvo KR
Int J Lab Hematol; 2019 May; 41 Suppl 1():131-141. PubMed ID: 31069978
[TBL] [Abstract][Full Text] [Related]
13. Recurring diagnostic problems in the pathology of the myelodysplastic syndromes.
Rosati S; Anastasi J; Vardiman J
Semin Hematol; 1996 Apr; 33(2):111-26. PubMed ID: 8722682
[No Abstract] [Full Text] [Related]
14. Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia.
Vinh DC; Patel SY; Uzel G; Anderson VL; Freeman AF; Olivier KN; Spalding C; Hughes S; Pittaluga S; Raffeld M; Sorbara LR; Elloumi HZ; Kuhns DB; Turner ML; Cowen EW; Fink D; Long-Priel D; Hsu AP; Ding L; Paulson ML; Whitney AR; Sampaio EP; Frucht DM; DeLeo FR; Holland SM
Blood; 2010 Feb; 115(8):1519-29. PubMed ID: 20040766
[TBL] [Abstract][Full Text] [Related]
15. Neural cell adhesion molecule (CD56)-positive acute myelogenous leukemia and myelodysplastic and myeloproliferative syndromes.
Mann KP; DeCastro CM; Liu J; Moore JO; Bigner SH; Traweek ST
Am J Clin Pathol; 1997 Jun; 107(6):653-60. PubMed ID: 9169661
[TBL] [Abstract][Full Text] [Related]
16. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome.
Hsu AP; Sampaio EP; Khan J; Calvo KR; Lemieux JE; Patel SY; Frucht DM; Vinh DC; Auth RD; Freeman AF; Olivier KN; Uzel G; Zerbe CS; Spalding C; Pittaluga S; Raffeld M; Kuhns DB; Ding L; Paulson ML; Marciano BE; Gea-Banacloche JC; Orange JS; Cuellar-Rodriguez J; Hickstein DD; Holland SM
Blood; 2011 Sep; 118(10):2653-5. PubMed ID: 21670465
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of multilineage dysplasia in de novo acute myeloid leukemia patients with intermediate-risk cytogenetics is dependent on NPM1 mutational status.
Díaz-Beyá M; Rozman M; Pratcorona M; Torrebadell M; Camós M; Aguilar JL; Esteve J
Blood; 2010 Dec; 116(26):6147-8. PubMed ID: 21183700
[No Abstract] [Full Text] [Related]
18. A family inheriting different subtypes of acute myelogenous leukemia.
Horwitz M; Sabath DE; Smithson WA; Radich J
Am J Hematol; 1996 Aug; 52(4):295-304. PubMed ID: 8701948
[TBL] [Abstract][Full Text] [Related]
19. MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations.
McReynolds LJ; Yang Y; Yuen Wong H; Tang J; Zhang Y; Mulé MP; Daub J; Palmer C; Foruraghi L; Liu Q; Zhu J; Wang W; West RR; Yohe ME; Hsu AP; Hickstein DD; Townsley DM; Holland SM; Calvo KR; Hourigan CS
Leuk Res; 2019 Jan; 76():70-75. PubMed ID: 30578959
[TBL] [Abstract][Full Text] [Related]
20. ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia-related changes and normal karyotype.
Prats-Martín C; Burillo-Sanz S; Morales-Camacho RM; Pérez-López O; Suito M; Vargas MT; Caballero-Velázquez T; Carrillo-Cruz E; González J; Bernal R; Pérez-Simón JA
Cancer Med; 2020 Jun; 9(11):3637-3646. PubMed ID: 32216059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
